News from QIAGEN N.V. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jan 18, 2018, 16:05 ET QIAGEN Receives FDA Approval to Expand Use of EGFR Test in Lung Cancer

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has approved a PMA...


Jan 18, 2018, 05:41 ET QIAGEN N.V. to Report Fourth Quarter and Full Year of 2017 Results

QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) plans as previously announced to release its report on results for the fourth quarter and...


Jan 08, 2018, 02:00 ET QIAGEN adds to Growth Momentum in Next-Generation Sequencing with 2018 Plans for Significant Portfolio Enhancements

- Goal set to exceed $140 million of NGS-related sales in 2018, up from over $115 million in 2017 - New Enterprise Genomics...


Jan 08, 2018, 02:00 ET QIAGEN and DiaSorin Partner to Offer Fully Automated Tuberculosis Detection With QuantiFERON-TB Gold Plus Available on LIAISON Analyzer Systems

- QIAGEN's QuantiFERON-TB customers to gain access to fully automated workflow solution - DiaSorin to add novel content to...


Dec 22, 2017, 16:15 ET QIAGEN to Take Impairment on Deferred Tax Assets, Informs on Expected Impacts of New U.S. Tax Law and Other Changes in Global Tax Environment

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announces that, mainly as a consequence of the new U.S. tax legislation, it will take an...


Dec 15, 2017, 16:05 ET QIAGEN and Oxford Immunotec Settle Patent Infringement Lawsuit

QIAGEN N.V. (NASDAQ: QGEN, Frankfurt Stock Exchange: QIA) and Oxford Immunotec Ltd. (NASDAQ: OXFD) announced today that they have reached a...


Dec 08, 2017, 16:05 ET QIAGEN to Transfer U.S. Listing of Global Shares to NYSE

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that it is transferring the U.S. listing of its global shares to the New...


Nov 15, 2017, 16:05 ET QIAGEN Advances Precision Medicine by Automating Guidelines on Cancer Variants in Industry-leading QIAGEN Clinical Insight Software

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today launched enhancements in its QIAGEN Clinical Insight (QCI) bioinformatics software...


Nov 14, 2017, 16:17 ET QIAGEN's GeneReader NGS System Delivers Accuracy and Ease of Use for Clinical Research in Oncology

QIAGEN N.V. (NASDAQ: QGEN) (Frankfurt Prime Standard: QIA) today announced new studies highlighting the outstanding analytical performance and...


Nov 13, 2017, 16:02 ET QIAGEN Celebrates Surpassing 2,000 Cumulative Placements of QIAsymphony

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the 2,000th placement of QIAsymphony, the leading Sample to Insight...


Nov 06, 2017, 16:05 ET QIAGEN Reports Results for Third Quarter and First Nine Months of 2017

- Solid Q3 2017 performance in line with full-year ambitions: - Net sales $364.0 million (+7% actual, +7% CER); adjusted net sales...


Oct 24, 2017, 11:25 ET QIAGEN and ICMP Launch Next-Generation DNA Testing Solutions for Identifying Missing Persons

The International Commission on Missing Persons (ICMP) today announced the launch of a cutting-edge next-generation sequencing (NGS) workflow...


Oct 19, 2017, 16:36 ET QIAGEN Announces High Accuracy of Bioinformatics Solutions in Women's Health Genetic Screening

QIAGEN (NASDAQ: QGEN; Frankfurt Stock Exchange: QIA) today announced the results of a study evaluating the accuracy of the QIAGEN Clinical Insight...


Oct 16, 2017, 06:20 ET QIAGEN N.V. to Report Third Quarter and First Nine Months of 2017 Results

QIAGEN N.V. (NASDAQ: QGEN) (Frankfurt: QIA) plans as previously announced to release its report on results for the third quarter and first nine...


Oct 12, 2017, 16:05 ET QIAGEN Bioinformatics and NGS Solutions Enable Genomic Breakthroughs

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its Sample to Insight solutions, from next-generation sequencing...


Oct 09, 2017, 16:05 ET QIAGEN and CENTOGENE to Collaborate in Bioinformatics for Genetic Diseases

QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) and CENTOGENE AG today announced a collaboration and co-marketing agreement to provide...


Oct 05, 2017, 16:05 ET QIAGEN Launches Fourth-generation QuantiFERON®-TB Gold Plus in the U.S.

QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. launch of QuantiFERON®-TB Gold Plus (QFT®-Plus), the fourth...


Oct 02, 2017, 16:05 ET QIAGEN Achieves ISO Certification for State-of-the-art Quality in Forensics

QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its manufacturing and supply chain for consumables and other products...


Aug 21, 2017, 16:05 ET QIAGEN and Clinical Genomics Partner on Liquid Biopsies to Monitor Patients for Recurrence of Colorectal Cancer

QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) and Clinical Genomics, a private company developing evidence-based diagnostic tools for...


Jul 27, 2017, 11:16 ET QIAGEN Reports Results for Second Quarter and First Half of 2017

- Strong Q2 2017 results reaffirm QIAGEN on track to achieve full-year goals: - Net sales $349.0 million (+4% actual); adjusted net...


Jul 13, 2017, 04:02 ET QIAGEN N.V. to Report Second Quarter and First Half of 2017 Results

QIAGEN N.V. (Nasdaq: QGEN) (Frankfurt: QIA) plans as previously announced to release its report on results for the second quarter and first half of...


Jun 22, 2017, 08:04 ET French health system approves reimbursement of QIAGEN's QuantiFERON latent TB test

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that France's Ministry of Health and Social Affairs has approved...


Jun 22, 2017, 08:00 ET Approbation par le système d’assurance maladie français du remboursement de QuantiFERON, le test de dépistage de l’infection tuberculeuse latente de QIAGEN

Le test de choix pour le dépistage de la tuberculose latente sera remboursé par l'assurance maladie nationale QIAGEN N.V. (NASDAQ : QGEN ;...


Jun 08, 2017, 09:00 ET QIAGEN's QuantiFERON®-TB Gold Plus gains U.S. FDA approval

QIAGEN N.V. (NASDAQ: QGEN) (Frankfurt Prime Standard: QIA) today announced the U.S. regulatory approval of QuantiFERON®-TB Gold Plus (QFT®-Plus)...


Jun 06, 2017, 02:00 ET QIAGEN receives U.S. FDA approval for cytomegalovirus (CMV) testing on automated QIAsymphony platform

QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received premarket approval from the U.S. Food and Drug...